首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Antimicrobial Susceptibility Patterns of Aeromonas jandaei A. schubertii A. trota and A. veronii Biotype veronii
【2h】

Antimicrobial Susceptibility Patterns of Aeromonas jandaei A. schubertii A. trota and A. veronii Biotype veronii

机译:詹氏气单胞菌舒伯特氏菌曲霉和维罗氏菌生物型的抗菌药敏模式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fifty-six isolates of four Aeromonas species, which have been documented as causative agents of human infections or isolated from human clinical specimens, were subjected to antimicrobial susceptibility testing using a MicroScan WalkAway conventional (overnight incubation) gram-negative panel. The four species tested and the number of isolates of each were as follows: Aeromonas jandaei, 17; A. schubertii, 12; A. trota, 15; and A. veronii biotype veronii, 12. All isolates of A. trota were susceptible to all antimicrobial agents tested, except cefazolin (20% of isolates were resistant) and cefoxitin (13% of isolates were resistant). All isolates of A. schubertii and A. veronii biotype veronii, as well as 88% of A. jandaei isolates, were resistant to ampicillin. Resistance to ampicillin-sulbactam ranged from 25% of A. schubertii strains to 100% of A. veronii biotype veronii strains. Cefazolin resistance ranged from 17% of A. veronii biotype veronii isolates to 59% of A. jandaei isolates. Imipenem resistance was detected in 65% of A. jandaei strains and 67% of A. veronii biotype veronii strains. A. jandaei displayed resistance to piperacillin and ticarcillin in 53 and 71% of the isolates, respectively. A. veronii biotype veronii strains were 100% susceptible to piperacillin and 100% resistant to ticarcillin. These antibiogram data may be useful in establishing the identification of these four species when members of the genus Aeromonas are isolated from human clinical sources.
机译:使用MicroScan WalkAway常规(过夜孵育)革兰氏阴性试剂盒对四种气单胞菌的五十六种分离物(已被证明是人类感染的病原体或从人类临床标本中分离)进行了抗菌药敏测试。所测试的四个物种以及每个物种的分离物数目如下:Aeromonas jandaei,17;舒伯特A.,12; trota,15岁;和veronii a。veronii生物型veronii,12。除了头孢唑林(20%的菌株有抗药性)和头孢西丁(13%的菌株有抗药性)外,所有曲霉农杆菌都对所有抗菌药物敏感。 schubertii和veronii生物型veronii的所有分离株以及88.%的A. jandaei分离株均对氨苄青霉素具有抗性。对氨苄西林-舒巴坦的耐药性范围从舒氏曲霉菌株的25%到veronii生物型veronii菌株的100%。头孢唑林的耐药性范围从ver.ii生物型veronii分离株的17%到jandei菌株的59%。在65%的詹氏曲霉菌株和67%的veronii生物型veronii菌株中检测到亚胺培南抗性。詹氏曲霉分别对53%和71%的分离株表现出对哌拉西林和替卡西林的抗性。 A。 veronii生物型veronii菌株对哌拉西林的敏感性为100%,对替卡西林的抗性为100%。当从人类临床来源分离出 Aeromonas 属的成员时,这些抗菌谱数据可能有助于确定这四个物种。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号